Briefs

Joby Aviation Inc. (NYSE:JOBY) and L3Harris Technologies (NYSE:LHX) announced Friday that they are partnering to develop a hybrid vertical takeoff and landing aircraft designed for U.S. military use. The gas turbine-powered aircraft will be capable of crewed and fully autonomous operations,...

Rising interest rates and economic uncertainties are reshaping the landscape for homebuilders, challenging companies to adapt their strategies. As the housing market navigates these shifts, PulteGroup Inc. (NYSE:PHM) stands out with its latest financial performance, revealing both the pressures and...

Snap-On Inc. (NYSE:SNA) reported better-than-expected second-quarter 2025 results, surpassing both revenue and earnings consensus estimates. Here's a breakdown of the report: Quarterly net sales reached $1.179 billion flat year-over-year increase and above the consensus estimate of $1.16 billion....

Bank of America (BofA) Securities updated the earnings model for Pfizer Inc. (NYSE:PFE). The company will announce second-quarter 2025 earnings on August 5. According to data from Benzinga Pro, analysts estimate adjusted earnings of 57 cents per share on sales of $13.41 billion. In the second...

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) on Sunday presented new exploratory analyses from its Phase 2 PREVENT and Phase 2b trials of avexitide—an investigational GLP-1 receptor antagonist—at the Endocrine Society's annual meeting (ENDO 2025). The drug targets post-bariatric hypoglycemia (PBH),...

Nebius Group (NASDAQ:NBIS) stock surged on Monday after Goldman Sachs analyst Alexander Duval initiated coverage with a Buy rating and announced a price target of $68. Duval noted that Nebius is emerging as a key player in the fast-growing AI Neoclouds space — a niche segment within the broader GPU...

The U.S. Food and Drug Administration issued on Friday a Complete Response Letter for Ultragenyx Pharmaceutical Inc.’s (NASDAQ:RARE) Biologics License Application (BLA) for UX111 (ABO-102) AAV gene therapy for Sanfilippo syndrome type A (MPS IIIA).  In the CRL, the FDA requested that the...

Health insurer Elevance Health Inc. (NYSE:ELV) is scheduled to release its second quarter 2025 financial results on July 17. Analysts estimate adjusted earnings of $9.197 per share on sales of $48.24 billion, as per data from Benzinga Pro. UnitedHealth Group Inc. (NYSE:UNH) has been the first major...

Sonnet BioTherapeutics Inc. (NASDAQ:SONN) stock surged Monday amid high trading volume following news of a transformative business combination with Rorschach I, backed by Atlas Merchant Capital and Paradigm. The deal will create Hyperliquid Strategies Inc., a public cryptocurrency treasury company...

XCF Global, Inc. (NASDAQ:SAFX) stock is trading higher on Thursday, with a session volume of 95.7 million compared to the average volume of 6.21 million as per data from Benzinga Pro. A key player in decarbonizing the aviation industry through Synthetic Aviation Fuel (SAF), the company shared its...

Enphase Energy Inc. (NASDAQ:ENPH) on Thursday announced that it has expanded the rollout of its IQ EV Charger 2 to four additional European countries, Greece, Romania, Ireland, and Poland. The charger can function either alongside Enphase solar and battery systems or as a standalone unit for...

BIT Mining Limited (NYSE:BTCM) stock is trading higher on Thursday, with a session volume of 79.2 million compared to the average volume of 67.6K as per data from Benzinga Pro. BIT Mining announced a strategic shift on Thursday with its expansion into the Solana ecosystem, marking a critical...

Helen of Troy Limited (NASDAQ:HELE) saw its shares tumble by over 20% on Thursday after the company reported a disappointing first quarter. The stark miss not only highlights the company’s struggles under the weight of ongoing tariff pressures but also raises serious concerns for investors...

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) and Mereo BioPharma Group plc (NASDAQ:MREO) stocks are plunging on Thursday. What Happened? The companies on Wednesday announced that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in pediatric and...

FuelCell Energy Inc. (NASDAQ:FCEL) on Thursday announced that it has joined forces with AI infrastructure developer Inuverse to explore the phased deployment of up to 100 megawatts of fuel cell power at South Korea's forthcoming AI Daegu Data Center (AI DDC). The companies signed a non-binding...